I’d buy these penny shares with potential for price growth

These penny shares have been performing strongly and have been seeing strong share price growth. Could there be further to rise?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image of person checking their shares portfolio on mobile phone and computer

Image source: Getty Images.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

When it comes to penny shares, I’m not looking to invest in the very smallest, riskiest companies. For me, the chance of losing all my money is off-putting. Instead, I’m looking for companies that have a share price under 100p per share, hence they’re ‘penny shares’ and have significant potential for growth.

A beneficiary of Covid 

One such penny share could be Open Orphan (LSE: ORPH). It says it’s a “world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials.” It provides services to large pharmaceutical companies to assist clinical trials.

The vaccine development market is expanding considerably as a result of Covid-19, so there’s potential for years of growth. Another positive is that the executive chairman owns just over 6% of the shares, which is a sizeable holding in a public company. He’s a co-founder, but I still find that amount of ‘skin in the game’ reassuring.

Open Orphan was granted a £40m contract by the UK Government, showing there’s significant demand for its services.

Disposals could generate significant value. Open Orphan plans to spin off at least four major assets as separate companies. These include selling its novel disease data platform Disease in Motion to wearables giants like Fitbit. The company seems to have many strings to its bow. 

That said, I’d be wary of investing too much in Open Orphan because it’s a small biotech company, making it inherently risky. And there’s a valuation risk. In just a year, the shares have gone up 400%. Also, the conditions that the company expects going forward (an increased focus on pandemics) may actually recede and lessen demand for its services.

Another penny share with plenty of potential

DX plc (LSE: DX) is a courier and logistics company. For the 27 weeks ended 2 January 2021 the financials look strong. Revenue and cash flow were both strongly up, while net debt fell. Net cash at the end of the period was £14.1m.

The chief executive has led other successful logistics businesses. That’s a good sign I think. He co-founded Nightfreight plc, a logistics company and has been involved in the industry for 45 years so should be able to help the logistics group grow. He’s also previously worked with the current DX chairman at another business, so they know each other well.

Possible downsides to investing in DX Group

On the downside, the balance sheet doesn’t seem in the best of shape with current liabilities higher than current assets, which may weaken its working capital. This is the opposite of what I want to see in an investment.

For example, payables increased dramatically between the ned of 2019 and the start of 2021, which may make strong growth harder to come by. These bills, due to be paid in the next 12 months, total over £38m. That’s only £4.8m less than the total current assets (assets that will convert into cash within the next year). 

Yet its investment in things like new depots and technology has helped it win new business. That makes me think DX Group could do well going forward. It’s a cash-generative business, which is also good for shareholders. If the balance sheet improves, it could do very well, in my opinion. I’m monitoring the company and may add this penny share to my own portfolio. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Andy Ross owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Is £4 a fair price for Rolls-Royce shares?

Our writer runs his slide rule over last year's FTSE 100 star performer and considers whether Rolls-Royce shares might now…

Read more »

Close-up of British bank notes
Investing Articles

Here’s how I’d target £130 per week in dividends from a Stocks and Shares ISA

Using a Stocks and Shares ISA as a dividend machine does not have to be hard work. Our writer explains…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

This 1 simple investing move accelerated Warren Buffett’s wealth creation

Warren Buffett has used this easy to understand investing technique for decades -- and it has made him billions. Our…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Down 6% in 2 weeks, the Lloyds share price is in reverse

After hitting a one-year high on 8 April, the Lloyds share price has suddenly reversed course. But as a long-term…

Read more »

Investing Articles

£3,000 in savings? Here’s how I’d use that to start earning a monthly passive income

Our writer digs into the details of how spending a few thousand pounds on dividend shares now could help him…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »